Drugs / Monovalent Subvirion A/H1N1 Influenza vaccine
Monovalent Subvirion A/H1N1 Influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00953524 | Aug 2009 → Mar 2010 | swine influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Monovalent Subvirion A/H1N1 Influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00953524 ↗ |
| Modality | Vaccine | “licensed monovalent pandemic H1N1 vaccine” PMID 20018365 ↗ Dec 2009 |
| Route | Intramuscular | “0.5 mL, Intramuscular on Day 0 and on Day 21” NCT00953524 ↗ |